Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Meditoxin vs Botox for Anhidrotic Area in Healthy Volunteers
NCT03647982Phase 1Completed
- Sponsor
- Medytox Inc.
- Start
- Mar 2018
- Primary completion
- Oct 2018
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 1, open-label trial of Meditoxin in hyperhidrosis (6 arms), sponsored by Medytox Inc. Primary endpoint: Anhidrotic Area at week 4. Started Mar 2018; status: completed.
02
Drugs
Meditoxin
03
Conditions
hyperhidrosis
Beyond the preview
Go deeper on NCT03647982.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03647982.